RIVERNORTH CAPITAL MANAGEMENT, LLC - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 22 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RIVERNORTH CAPITAL MANAGEMENT, LLC ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$2,753
-50.0%
34,4100.0%0.00%
Q4 2022$5,506
-8.2%
34,4100.0%0.00%
Q3 2022$6,0000.0%34,4100.0%0.00%
Q2 2022$6,000
-53.8%
34,4100.0%0.00%
Q1 2022$13,000
-61.8%
34,410
-1.7%
0.00%
-100.0%
Q4 2021$34,000
+9.7%
34,9970.0%0.00%
-50.0%
Q3 2021$31,00034,9970.00%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q3 2021
NameSharesValueWeighting ↓
ANGELO GORDON & CO., L.P. 60,000$584,0000.06%
Empery Asset Management, LP 39,700$6,0000.03%
Radcliffe Capital Management, L.P. 80,001$779,0000.02%
Anson Funds Management LP 15,000$146,0000.01%
Segantii Capital Management Ltd 30,000$292,0000.01%
Arena Capital Advisors, LLC- CA 111,314$17,0000.00%
683 Capital Management, LLC 239,800$36,0000.00%
Atalaya Capital Management LP 100,000$15,0000.00%
MMCAP International Inc. SPC 159,802$24,0000.00%
MARSHALL WACE, LLP 54,995$536,0000.00%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders